Healthcare Realty Trust is undergoing a significant deleveraging and portfolio repositioning, with total assets down 27% to $9.0B and debt reduced 20% to $4.4B since early 2024. While NOI margin has recovered to 64.4% in 2026Q2 from negative levels, revenue co...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 30, 2026 | -$0.13-3276.6% vs -$0.00 | $282M+3.8% vs $272M |
Q2 2026 Apr 30, 2026 | $0.41+5.1% vs $0.39 | $279M-1.7% vs $284M |
Q1 2026 Feb 12, 2026 | $0.04-90.0% vs $0.40 | $286M+0.4% vs $285M |
Q4 2025 Oct 30, 2025 | -$0.17-661.3% vs -$0.02 | $287M-0.8% vs $290M |
The heavy selling pressure might have exhausted for Healthcare Realty Trust (HR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and tran
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo's ENHERTUÂ (fam-trastuzumab deruxtecan-nxki) demonstrated a stat
Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/url] that updated data, including overall survival (OS), from
Benchmark HR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Healthcare Realty Trust Incorporated (HR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $17.96 | $6.3B | -25.30 | -6.92% | -20.84% | -4.93% | 6.16% | |
| $20.48 | $14.12B | 204.80 | 4.52% | 8.6% | 2.89% | — | |
| $86.64 | $42.12B | 160.44 | 18.47% | 4.13% | 1.99% | — | |
| $229.94 | $165.69B | 165.42 | 35.82% | 10.67% | 3.08% | — | |
| $46.17 | $13.75B | 23.80 | 13.95% | 66.43% | 15.76% | — | |
| $35.74 | $94.26M | 115.29 | 7.08% | -8.18% | -2.31% | — |
Healthcare Realty Trust Incorporated (HR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Healthcare Realty Trust Incorporated (HR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 31, 2026·SEC
Jul 30, 2026·SEC
May 20, 2026·SEC
Get notified when HR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Healthcare Realty Trust Incorporated (HR) stock FAQ — growth, dividends, profitability & financials explained
Healthcare Realty Trust Incorporated (HR) reported $1.14B in revenue for fiscal year 2025. This represents a 3558% increase from $31.3M in 1996.
Healthcare Realty Trust Incorporated (HR) saw revenue decline by 6.9% over the past year.
Healthcare Realty Trust Incorporated (HR) reported a net loss of $86.9M for fiscal year 2025.
Yes, Healthcare Realty Trust Incorporated (HR) pays a dividend with a yield of 6.16%. This makes it attractive for income-focused investors.
Healthcare Realty Trust Incorporated (HR) has a return on equity (ROE) of -4.9%. Negative ROE indicates the company is unprofitable.
Healthcare Realty Trust Incorporated (HR) generated Funds From Operations (FFO) of $458.8M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Healthcare Realty Trust Incorporated (HR) offers a 6.16% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
